These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1095 related items for PubMed ID: 16874158
1. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study). Reiner Z, Mihatov S, Milicić D, Bergovec M, Planinc D, TASPIC-CRO Study Group Investigators. Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158 [Abstract] [Full Text] [Related]
4. Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study. Magnani B, Dal Palù C, Zanchetti A, MC'95 Investigators. Ital Heart J; 2002 Feb; 3(2):86-95. PubMed ID: 11926017 [Abstract] [Full Text] [Related]
9. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Anselmino M, Malmberg K, Ohrvik J, Rydén L, Euro Heart Survey Investigators. Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651 [Abstract] [Full Text] [Related]
15. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99]. Pajak A, Kawecka-Jaszcz K, Jankowski P, Bilo G, Dubiel JS, Maciejewicz J, Piotrowski W, Smielak-Korombel W, Tracz W. Przegl Lek; 2003 Apr; 60(3):136-41. PubMed ID: 14575013 [Abstract] [Full Text] [Related]
16. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, Oliveira SA, Ramires JA. Circulation; 2007 Mar 06; 115(9):1082-9. PubMed ID: 17339566 [Abstract] [Full Text] [Related]
17. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II). Soares PR, Hueb WA, Lemos PA, Lopes N, Martinez EE, Cesar LA, Oliveira SA, Ramires JA. Circulation; 2006 Jul 04; 114(1 Suppl):I420-4. PubMed ID: 16820611 [Abstract] [Full Text] [Related]
19. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study. Bradshaw PJ, Jamrozik K, Gilfillan I, Thompson PL. Am Heart J; 2004 Jun 04; 147(6):1047-53. PubMed ID: 15199354 [Abstract] [Full Text] [Related]
20. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis]. Rev Esp Salud Publica; 2000 Jun 04; 74(3):215-53. PubMed ID: 10918811 [Abstract] [Full Text] [Related] Page: [Next] [New Search]